Stocks
GlaxoSmithKline (GSK) Debt US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt, £ | 32 741 119 850 | 20 987 000 000 | 22 969 346 400 | 16 986 000 000 | 17 688 854 000 | 25 129 147 000 | |||
| Changes by years, y/y, % | -12% | -36% | +9% | -26% | +4% | -13.8% | |||
GlaxoSmithKline. Debt, £
GlaxoSmithKline. Debt, changes, %
GlaxoSmithKline (GSK) Debt US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt, £ | 23 791 104 000 | 23 781 053 900 | 23 895 938 000 | 17 688 854 000 | 25 129 147 000 | 25 129 147 000 | ||
| Changes by years, y/y, % | +6% | +11% | +49% | +4% | +6% | |||
| Changes by quarters, q/q, % | +40% | 0% | +0% | -26% | +42% | |||
